At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
intense pulsed lightdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Safety and Efficacy of Intense Pulse Light Treatment With Meibomian Gland Expression of Upper Eyelids for Dry Eye Disease
In Brief
A clinical study evaluating intense pulsed light for Dry Eye. Completed, enrolled 19 participants across 1 site.
Detailed Summary
Upper eyelid treatment has not been used with previously described methods of treatment of dry eye disease using intense pulsed light therapy because the upper lids disease was typically not as advanced as lower lid and because direct treatment of the upper lid was not felt to be necessary as each light pulse extended over the entire periorbita even when concentrated on the lower lid.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedSep 2018
Primary CompletionOct 2018
Study CompletionOct 2018
TodayJul 2026
First PostedSep 5, 2018
Enrollment StartSep 1, 2018
Primary CompletionOct 30, 2018
Study CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.8 years ago
Interventions
intense pulsed lightdevice
Use of 6 mm SapphireCool light guide to treat upper lid margins from tragus to tragus including the nose